Medicare Enrolled
Dr. Alan Rodney, MD
Hematology & Oncology · Webster, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rodney from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rodney?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rodney
Dr. Alan Rodney is a hematology & oncology specialist in Webster, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rodney performed 36,838 Medicare services across 1,371 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rodney received a total of $495,872 from 71 pharmaceutical and/or device companies across 863 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rodney is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 26% volume in TX
$495,872 industry payments
Medicare Practice Summary
Medicare Utilization ↗36,838
Medicare services
Top 26% in TX for hematology & oncology
1,371
Unique beneficiaries
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,939 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
26,010 | $0 | $5 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
5,900 | $0 | $2 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,083 | $0 | $3 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
586 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
579 | $7 | $36 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
254 | $10 | $64 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
245 | $95 | $368 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
194 | $69 | $250 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
157 | $8 | $49 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
146 | $6 | $31 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
121 | $7 | $431 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
111 | $51 | $313 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
76 | $5 | $26 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
75 | $34 | $143 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
59 | $91 | $357 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
53 | $11 | $96 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
43 | $102 | $707 |
| Liver function blood test panel | 36 | $7 | $48 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
21 | $130 | $565 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
18 | $56 | $821 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
18 | $90 | $372 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
15 | $97 | $470 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
14 | $187 | $1,067 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
12 | $23 | $157 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 12 | $90 | $657 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
71.1% high complexity
22.2% medium
6.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$495,872
Total received (2018-2024)
Avg $70,839/year across 7 years
Top 1% in TX for hematology & oncology
71
Companies
863
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$424,635 (85.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$56,652 (11.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,585 (2.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$80,072
2023
$68,862
2022
$91,924
2021
$16,257
2020
$29,475
2019
$117,791
2018
$91,492
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$239,872
Takeda Pharmaceuticals U.S.A., Inc.
$63,549
PharmaEssentia USA Corporation
$54,892
Astellas Pharma US Inc
$31,804
Merck Sharp & Dohme LLC
$30,635
Celgene Corporation
$26,380
AstraZeneca Pharmaceuticals LP
$12,336
Gilead Sciences, Inc.
$6,833
PFIZER INC.
$6,747
Novartis Pharmaceuticals Corporation
$5,321
Kite Pharma, Inc.
$3,898
Seattle Genetics, Inc.
$2,904
Incyte Corporation
$1,359
GlaxoSmithKline, LLC.
$1,322
Seagen Inc.
$783
BeiGene USA, Inc.
$663
Amgen Inc.
$546
MENARINI SILICON BIOSYSTEMS, INC.
$473
Daiichi Sankyo Inc.
$463
GENZYME CORPORATION
$426
Regeneron Healthcare Solutions, Inc.
$334
Janssen Biotech, Inc.
$330
Lilly USA, LLC
$311
Exelixis Inc.
$259
Genmab U.S., Inc.
$250
TESARO, Inc.
$247
Eisai Inc.
$192
Genentech USA, Inc.
$191
Mirati Therapeutics, Inc.
$185
Karyopharm Therapeutics Inc.
$165
Bayer HealthCare Pharmaceuticals Inc.
$160
Pharmacosmos Therapeutics Inc.
$154
Apellis Pharmaceuticals, Inc.
$152
EISAI INC.
$129
G1 Therapeutics, Inc.
$119
Ipsen Biopharmaceuticals, Inc
$117
Merck Sharp & Dohme Corporation
$104
Pharmacyclics LLC, An AbbVie Company
$97
MorphoSys, US Inc.
$78
AVEO Pharmaceuticals, Inc.
$75
SANOFI-AVENTIS U.S. LLC
$75
ARRAY BIOPHARMA INC
$66
TAIHO ONCOLOGY, INC.
$64
Boehringer Ingelheim Pharmaceuticals, Inc.
$61
Kyowa Kirin, Inc.
$54
SOBI, INC
$51
Sobi, Inc
$47
Pharmacyclics LLC, an AbbVie Company
$44
EMD Serono, Inc.
$44
SpringWorks Therapeutics, Inc.
$42
Puma Biotechnology, Inc.
$40
ABBVIE INC.
$39
CTI BioPharma Corp.
$33
TerSera Therapeutics LLC
$28
JAZZ PHARMACEUTICALS INC.
$26
Deciphera Pharmaceuticals Inc.
$26
Bayer Healthcare Pharmaceuticals Inc.
$23
ADC Therapeutics America, Inc.
$22
Aveo Pharmaceuticals, Inc.
$22
Sirtex Medical Inc
$20
ImmunoGen, Inc.
$20
Pharming Healthcare, Inc.
$20
Mylan Institutional Inc.
$19
Rigel Pharmaceuticals, Inc.
$19
Blueprint Medicines Corporation
$19
Taiho Oncology, Inc.
$18
Adaptive Biotechnologies Corporation
$17
PUMA BIOTECHNOLOGY, INC.
$17
Myriad Genetic Laboratories, Inc.
$16
Sun Pharmaceutical Industries Inc.
$14
Clovis Oncology, Inc.
$11
Top 3 companies account for 72.3% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · Adcetris · Alecensa · Aranesp · BESPONSA · BESREMI · BLENREP · BOSULIF · BRACANALYSIS CDX · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · COSELA · Cabometyx · Cellsearch · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · ERLEADA · Empaveli · Enhertu · Epkinly · FOTIVDA · FRUZAQLA · GAZYVA · GILOTRIF · GLEEVEC · IBRANCE · ILARIS · IMBRUVICA · IMFINZI · INLYTA · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · NINLARO · Nplate · OGIVRI · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · PADCEV · PIQRAY · POTELIGEO · PROMACTA · Padcev · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RUCONEST · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · Stivarga · TABRECTA · TAFINLAR · TAGRISSO · TALVEY · TECENTRIQ · TUKYSA · Tazverik · Trodelvy · VENCLEXTA · VERZENIO · VONJO · Venclexta · Vonjo · WELIREG · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · YONSA · ZEJULA · ZEPZELCA · Zoladex · Zydelig · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (86%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for hematology & oncology in TX.
Equivalent to $1,346 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
180
Per 100K population
3.8
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE CLEAR LAKE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Rodney is a mixed practice specialist, with above-average Medicare volume (top 26% in TX), with speaking/promotional industry engagement in the top 1% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Rodney experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Rodney performed 26,010 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rodney receive payments from pharmaceutical companies?
Yes. Dr. Rodney received a total of $495,872 from 71 companies across 863 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rodney's costs compare to other hematology & oncology specialists in Webster?
Dr. Rodney's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rodney) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Webster
Browse hematology & oncology specialists in Webster ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
PharmaEssentia USA Corporation Payments to Doctors
See all physicians who received payments from PharmaEssentia USA Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology